Cardiomyopathy
Cardiomyopathy refers to a group of primary diseases affecting the heart muscle, causing it to enlarge, thicken, or become stiffer, which impairs the heart’s ability to effectively pump blood. Early stages may present few symptoms, but as the disease progresses, it can lead to shortness of breath, fatigue, leg swelling, irregular heartbeats, fainting, and an increased risk of sudden cardiac death.
Health Outcomes
- Changed Heart Rate
- Developed Endocarditis
- Elevated Lactate Levels
- Extended Cardiac Transplant Survival
- Improved Cardiac Function
- Improved Cardiac Muscle Contractile Performance
- Improved Cardiac Muscle Structural Integrity
- Improved Cardiovascular Disease Outcomes
- Improved Cardiovascular Function
- Improved Diastolic Function
- Improved Exercise Stress Test Grade
- Improved Inotropic Function
- Improved Left Ventricular Ejection Fraction
- Improved Left Ventricular Global Longitudinal Strain
- Improved Myocardial Strain
- Improved Myocardial Strain Rate
- Improved Right Ventricular Function
- Improved Systolic Function
- Increased Organ Weights
- Preserved Cardiac Function
- Prolonged Cardiac Allograft Survival
- Reduced Cardiac Arrest Risk
- Reduced Cardiac Function
- Reduced Cardiac Hypertrophy
- Reduced Cardiac Output
- Reduced Cardiovascular Dysfunction
- Reduced Coxsackievirus B3 Viral Load
- Reduced Heart Failure
- Reduced Inotropic Support Requirement
- Reduced Iron-Corrected T1
- Reduced Left Ventricular End-Diastolic Volume
- Reduced Myocardial Injury Cytokines
- Reduced Organ Failure Severity
- Reduced Stroke Volume
- Reduced Troponin I Level
- Reduced Trypanosoma cruzi Parasitaemia